Pre-informed patients and clinical trial recruitment

News that GlaxoSmithKline is facing difficulties enrolling enough patients in a clinical trial for its diabetes drug Avandia should come as no surprise to readers of my book, Get to Market Now.  The pre-informed patient is beginning to impact drug development and postmarket clinical trials…  Continue reading at ComplianceZen.com →